Syndexa Pharmaceuticals' Grant

Syndexa Pharmaceuticals raised a round of funding on October 28, 2009. Investors include Qualifying Therapeutic Discovery Project.

Syndexa Pharmaceuticals is dedicated to the discovery and development of drugs targeting biological mechanisms for the treatment and prevention of metabolic diseases including obesity, type 2 diabetes…

Articles about Syndexa Pharmaceuticals' Grant: